CalciMedica, Inc. (CALC)

CalciMedica Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-34.36	-9.14	-35.82	-34.72	-44.09
Depreciation & Amortization	0.06	0.05	0.52	0.4	0.3
Share-Based Compensation	12.04	1.81	5.38	1.79	0.74
Other Operating Activities	-3.47	-5.79	-1.57	-6.72	4.78
Operating Cash Flow	-25.73	-11.76	-31.5	-32.06	-31.22
Capital Expenditures	-0.08	-0	-0.49	-1.02	-0.61
Change in Investments	8.96	0	11.24	-41.54	-20.02
Investing Cash Flow	8.88	-0	10.75	-42.56	-20.62
Share Issuance / Repurchase	10.59	0.02	0.7	96.33	0.13
Debt Issued / Paid	0	8.46	0	0	0
Other Financing Activities	10.31	-	-	-4.16	54.74
Financing Cash Flow	20.9	8.48	0.7	92.17	54.87
Net Cash Flow	4.05	-3.29	-20.05	17.55	3.04
Free Cash Flow	-25.81	-11.76	-31.99	-33.09	-31.82
Free Cash Flow Per Share	-5.75	-143.00	-21.13	-69.99	-337.51

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).